CMS gives broad COVID-19 test payment-setting authority to MACs
The Centers for Medicare & Medicaid Services yesterday said that until Medicare sets national payment rates for COVID-19-related testing claims, its Medicare Administrative Contractors have authority to set payment amounts in their respective jurisdictions.
The policy applies to claims received for newly created Healthcare Common Procedure Coding System codes and includes two codes used by laboratories to bill for certain COVID-19 lab tests, including serology tests. There continues to be no cost-sharing with Medicare patients for these tests.
Related News Articles
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…